Target Name: Integrin alpha5beta3 receptor
NCBI ID: P12983
Review Report on Integrin alpha5beta3 receptor Target / Biomarker Content of Review Report on Integrin alpha5beta3 receptor Target / Biomarker
Integrin alpha5beta3 receptor
Other Name(s): None

Alpha5beta3 Receptor: Potential Drug Target and Biomarker for Many Diseases

The Integrin alpha5beta3 receptor is a protein that is expressed in many different tissues throughout the body. It is a member of the integrin family, which is a group of transmembrane proteins that play a critical role in cell-cell adhesion. The alpha5beta3 receptor is involved in many different processes in the body, including cell signaling, tissue repair, and inflammation.

One of the key functions of the alpha5beta3 receptor is its role in cell signaling. It is involved in the formation of tight junctions, which are specialized junctions that form between cells and are important for maintaining tissue structure and function. The alpha5beta3 receptor is also involved in the regulation of cell signaling pathways, including the T cell receptor signaling pathway.

Another function of the alpha5beta3 receptor is its role in tissue repair. When a tissue is damaged or destroyed, the alpha5beta3 receptor helps to stimulate the body's natural repair mechanisms. It is involved in the formation of new blood vessels, the growth of new tissue, and the regulation of cell proliferation.

The alpha5beta3 receptor is also involved in inflammation. When the body is exposed to an infection, the alpha5beta3 receptor helps to regulate the immune response. It is involved in the regulation of T cell activity, the production of antibodies, and the formation of immune memory.

In addition to its role in cell signaling and tissue repair, the alpha5beta3 receptor is also involved in the regulation of pain. When the body is experiencing pain, the alpha5beta3 receptor helps to regulate the pain signaling pathway. It is involved in the production of pain signals, the regulation of pain sensitivity, and the modulation of pain perception.

The alpha5beta3 receptor is also a potential drug target. Many diseases, including cancer, heart disease, and diabetes, are characterized by the breakdown of tight junctions and the failure of the immune system. The alpha5beta3 receptor plays a critical role in these processes, and targeting it may be a promising new approach to treating these diseases.

In conclusion, the alpha5beta3 receptor is a complex protein that is involved in many different processes in the body. It is a potential drug target and may be a useful biomarker for the diagnosis and treatment of many different diseases. Further research is needed to fully understand the role of the alpha5beta3 receptor in cell signaling, tissue repair, inflammation, and pain.

Protein Name: Integrin Alpha5beta3 Receptor

The "Integrin alpha5beta3 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Integrin alpha5beta3 receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK | IQCM | IQCN | IQGAP1 | IQGAP2 | IQGAP3 | IQSEC1 | IQSEC2 | IQSEC3 | IQSEC3P3 | IQUB